Health Care & Life Sciences » Pharmaceuticals | Clinuvel Pharmaceuticals Ltd.

Clinuvel Pharmaceuticals Ltd.

Clinuvel Pharmaceuticals Ltd.
Stock Exchange Other OTC
EPS
$0.24
Market Cap
$1.16 B
Shares Outstanding
47.82 M
Public Float
-
Clinuvel Pharmaceuticals Ltd. ADR
Stock Exchange Other OTC
EPS
$0.24
Market Cap
$1.14 B
Shares Outstanding
48.96 M
Public Float
-
Clinuvel Pharmaceuticals Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0.32
Market Cap
AUD1.63 B
Shares Outstanding
48.96 M
Public Float
36.67 M
Clinuvel Pharmaceuticals Ltd.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
47.86 M
Public Float
-

Profile

Address
15 Queen Street
Melbourne Victoria (VIC) 3000
Australia
Employees -
Website http://www.clinuvel.com
Updated 07/08/2019
Clinuvel Pharmaceuticals Ltd. is a global biopharmaceutical company. It engages in the the development of SCENESSE, its proprietary photoprotective drug. It also offers drugs for the treatment of various skin disorders.

Financials

View All

Philippe J. Wolgen
Chief Executive Officer, MD & Director
Stanley R. McLiesh
Non-Executive Chairman